Prescription Drugs Market Research Reports & Industry Analysis
The prescription drugs industry is a key cornerstone of healthcare, delivering vital medications that improve and save lives. As this industry continues to evolve, understanding its nuances can be an ongoing challenge. MarketResearch.com provides hundreds of authoritative prescription drugs market research reports to help stakeholders understand the shifting market landscape and devise effective business strategies.
The Latest Prescription Drugs Market Analysis
- We provide data-packed reports on a wide range of product types, therapeutic areas, regions, and companies.
- Our research includes in-depth analyses of prescription drug market size, growth forecasts, and drivers and challenges.
- In addition, we cover the rise of personalized medicine and gene therapies, as well as regulatory issues and pricing models.
Your Dedicated Research Partner
As the prescription drugs industry shifts and changes, MarketResearch.com equips you with the tools to thrive. Trusted for decades as a reliable research partner, our clients include top pharmaceutical companies, investment banks, and universities. Whether you are exploring new markets or seeking to futureproof your business, our prescription drugs industry research reports offer a wealth of knowledge to inform your strategy. Get started by exploring our vast selection of reports on the prescription drugs industry today.
Prescription Drugs Industry Research & Market Reports
-
INP20 Emerging Drug Insight and Market Forecast – 2032
... INP20 for Food Allergy in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with a detailed ... Read More
-
RNS60 Emerging Drug Insight and Market Forecast – 2032
... of the RNS60 for Amyotrophic Lateral Sclerosis in 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019 –2032 is provided in this report along ... Read More
-
NYX-783, Emerging Drug Insight and Market Forecast – 2032
... of the NYX-783 for Post-traumatic Stress Disorder in 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019 –2032 is provided in this report along ... Read More
-
HMI-102, Emerging Drug Insight and Market Forecast – 2032
... HMI-102 for Phenylketonuria (PKU) in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with a detailed ... Read More
-
XYWAV, Drug Insight and Market Forecast – 2032
... XYWAV for Excessive Daytime Sleepiness (EDS) in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with ... Read More
-
ENTYVIO (Vedolizumab) Drug Insight and Market Forecast – 2032
... of the ENTYVIO (Vedolizumab) for Crohn’s disease (CD) in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report ... Read More
-
Global Prescription Lens Market Size, Share & Industry Trends Analysis Report By Coating, By Application (Myopia, Hyperopia/Hypermetropia, Astigmatism and Presbyopia), By Type, By Regional Outlook and Forecast, 2022 - 2028
... size is expected to reach $63.8 billion by 2028, rising at a market growth of 5.4% CAGR during the forecast period. Whether the user is nearsighted, farsighted, or requires numerous prescriptions in a single lens, ... Read More
-
North America Prescription Lens Market Size, Share & Industry Trends Analysis Report By Coating, By Application (Myopia, Hyperopia/Hypermetropia, Astigmatism and Presbyopia), By Type, By Country and Growth Forecast, 2022 - 2028
... Lens Market would witness market growth of 4.9% CAGR during the forecast period (2022-2028). Progressive lenses, commonly referred to as "no-line" bifocals, are fantastic for the majority of people but can cause issues for individuals. ... Read More
-
Online Pharmaceutical Sales in Australia - Industry Market Research Report
... shop-front pharmacy. The industry excludes establishments that operate several physical stores that are supplemented with complementary online operations. This report covers the scope, size, disposition and growth of the industry including the key sensitivities and ... Read More
-
Pharmaceuticals Wholesaling in Australia - Industry Market Research Report
... to hospitals, veterinarians and retail outlets such as pharmacies and supermarkets. This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year ... Read More
-
Genital Herpes Treatment Market - Global Outlook and Forecast 2022-2027
... is a widespread infection worldwide. HSV-1 causes infection in or around the mouth (oral herpes), but it can also cause genital herpes. Herpes simplex virus type 2 (HSV-2) causes genital herpes, a dangerous sexually transmitted ... Read More
-
Pain Management Drugs Market, by Drug Class (Opioids, NSAIDs, Anticonvulsants, Antidepressants, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Pain management medications are specific drug classes, which have pharmacological actions on pain receptors and work against the pain symptoms. These medications include opioids, ... Read More
-
Investigation Report on China's Infliximab Market 2022-2031
... a variety of autoimmune diseases, including Crohn's disease, ulcerative colitis, rheumatoid arthritis, and ankylosing spondylitis. Infliximab was developed by Johnson & Johnson. In 2007, Infliximab entered the Chinese market. The Chinese infliximab market is completely ... Read More
-
Investigation Report on China's Aflibercept Market 2022-2031
... Bayer. Regeneron has exclusive sales rights in the U.S. market, while Bayer obtains exclusive sales rights outside the U.S. Their Aflibercept, EYLEA was launched in China in 2018. By July 2022, Bayer AG is the ... Read More
-
Naloxone Market, by Strength (2.0 mg/0.1 ml and 4.0 mg/ml, 1 mg/ml, 0.4 mg/ml, and Others), by Route of Administration (Intranasal, Intramuscular/Subcutaneous, and Intravenous), by Distribution Channel (Hospitals, (Public Hospitals and Private Hospitals), Clinics (Including Addiction Clinics), Retail Pharmacies, Emergency Medical Services (EMS), Military Facilities, Miscellaneous Facilities, Online Pharmacies, and Others (long-term care facilities, etc.)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Addiction Clinics), Retail Pharmacies, Emergency Medical Services (EMS), Military Facilities, Miscellaneous Facilities, Online Pharmacies, and Others (long-term care facilities, etc.)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, ... Read More
-
Thyroid Eye Disease Treatments Market Intelligence Report - Global Forecast to 2027
... a CAGR 9.43% during the forecast period. Market Statistics: The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better ... Read More
-
3D Printed Drugs Market Intelligence Report - Global Forecast to 2027
... 10.91% during the forecast period. Market Statistics: The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when ... Read More
-
Global Pharmaceutical Tracker, 2022
... and digital transformation will push top-line pharmaceutical industry growth and drive strong partnerships with small and mid-size pharma and digital solution vendors. The digital implosion is transforming the pharma business model to achieve digital maturity. ... Read More
-
Doxorubicin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Formulation (Lyophilized Powder and Doxorubicin Injection), Application (Breast Cancer, Kidney Cancer, Liver Cancer, Sarcoma, Ovarian Cancer, Lung Cancer, Leukemia, Multiple Myeloma, and Others), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy)
... Others), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) The global doxorubicin market is projected to reach US$ 1,983.40 million by 2028 from US$ 1,390.64 million in 2022; it is expected to register ... Read More
-
Global Non-steroidal Anti-inflammatory Drugs Market Size study, by Disease Indication (Arthritis, Migraine, Ophthalmic Diseases, Others) by Route of Administration (Oral, Topical, Others) by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)and Regional Forecasts 2022-2028.
... Non-steroidal Anti-inflammatory Drugs Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Nonsteroidal anti-inflammatory medications are ... Read More
-
Global Herpes Simplex Keratitis Treatment Market Size study, By Drug (Famciclovir, Valacyclovir, Acyclovir, Other Drugs), By Route of Administration (Topical, Injection, Oral), and Regional Forecasts 2022-2028
... USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. The Herpes Simplex Keratitis disease can be defined as infection ... Read More
-
Global Pharmacy Automation Market Size study, By Product (Automated Medication Dispensing and Storage Systems, Automated Packaging and Labelling Systems, Automated Tabletop Counters, Automated Medication Compounding Systems, Other Pharmacy Automation Systems), By End-User (Inpatient Pharmacies, Outpatient Pharmacies, Retail Pharmacies, Pharmacy Benefit Management Organizations and Mail-Order Pharmacies), and Regional Forecasts 2022-2028
... Pharmacies, Retail Pharmacies, Pharmacy Benefit Management Organizations and Mail-Order Pharmacies), and Regional Forecasts 2022-2028 Global Pharmacy Automation Market is valued at approximately USD XX million in 2021 and is anticipated to grow with a healthy ... Read More
-
Immuno-Oncology Drugs Global Market Opportunities And Strategies To 2031
... need to assess the global immuno-oncology drugs market as it emerges from the COVID 19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering ... Read More
-
Gynecology Drugs Global Market Opportunities And Strategies To 2031: COVID-19 Impact and Recovery
... and senior management with the critical information they need to assess the global gynecology drugs market as it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the most ... Read More
-
Overactive Bladder Treatment (OAB) Market by Drug type ( Anticholinergic (Solifenacin, Oxybutynin, Tolterodine, Darifenacin), Mirabegron), Botox, Neuromodulation, Disease Type (Idopathic OAB and Neurogenic OAB) and Region - Global Forecasts to 2027
... treatment market is projected to reach USD 4.2 billion by 2027 from USD 3.5 billion in 2022, at a CAGR of 3.6% during the forecast period. Rising prevalence of overactive bladder across the globe coupled ... Read More
Research Assistance
